Intuitive Surgical has enjoyed a sizable head start in the robotic surgery arena. But Medtronic is gaining momentum, having partnered in May with small-cap robotics player Mazor, and now detailing plans for its internally developed robotic surgery program.
Corporate wellness--and broader population health initiatives along those lines--is a small part of Fitbit's business right now. But the dominant wearable player is preparing to become a powerhouse tapping into the massive markets generated by major employers and insurers.
Medtronic is just a few days away from detailing pivotal data for its hybrid Closed Loop System at the American Diabetes Association conference. That's expected to be followed by a PMA submission in June, with an approval anticipated to follow in the spring.
While Ortho Clinical Diagnostics dragged a little since the Carlyle Group picked it up from Johnson & Johnson, it has tapped a new sales opportunity via a "strategic relationship" with laboratory automation giant Beckman Coulter.
Royal Philips launched a 13-country survey of about 25,000 patients and more than 2,500 healthcare providers, which it plans to conduct annually, asking if we're ready for the transformation of consumer and institutional healthcare through new tech. The first iteration of the survey suggests the answer could be--maybe we're not quite ready yet.
French digital health company Withings released its fourth-generation connected scale, dubbed Body Cardio. The most obvious upgrade users will see on the scale is the measurement for Pulse Wave Velocity, which offers insights on cardiac health and risk of hypertension or cardiovascular incidents.
Medtronic will report pivotal data for its Hybrid Closed Loop system for Type 1 diabetes on June 12 at the American Diabetes Association conference in New Orleans, LA.
Former Respironics executives have been quietly working on a startup for the last several years that's now been cleared by the FDA. Startup Cerêve has nabbed a regulatory nod for its sleep system as a prescription device to treat insomnia and is slated to launch it in the second half of next year.
The NIH launched the Genomic Data Commons on Monday to promote the sharing of genomic and clinical data. It's just the latest push in the National Cancer Moonshot created by Vice President Joe Biden earlier this year, an effort to "break down silos" between groups working in oncology.
Wall Street knew that Zimmer Biomet would have almost $5 billion in cash to spend over the next few years. And it expected the orthopedics company to plow much of that cash into M&A. Now, Zimmer has taken a step toward that with a purchase of spinal surgery player LDR Holding for about $1 billion.
Spine specialist NuVasive bolstered its product lineup when it acquired Ellipse in January. Now, the San Diego-based company is looking toward increasing its value-based healthcare offerings with the $98 million acquisition of Biotronic NeuroNetwork, which monitors patients' nervous systems during surgery.
Royal Philips and Pegasystems announced a partnership with the aim of helping managed care service providers and accountable care organizations better leverage health data and connected devices.
Last month, Theranos, in an attempt to appease CMS, said it had issued tens of thousands of corrected test results and thrown out two years' worth of results from its Edison testing machines. But now, the Palo Alto, CA-based company has reversed itself, saying less than 1% of the blood test results it provided were voided or corrected.
Medella Health has raised $1.4 million to develop a smart contact lens to continuously monitor blood glucose data and transmit the data to a mobile device.
Disposable vital sign patch company Vital Connect has bumped up its second institutional financing to $18 million, according to a recent SEC filing. The news comes after the Silicon Valley startup launched its VitalPatch earlier this year; this is the latest, smallest iteration of its wearable vital sign monitor.
Barely 6 months after raising a $38.5 million Series B to advance its neuromodulation implant to treat overactive bladder and fecal dysfunction, Axonics Modulation Technologies won a CE mark for the device.
The latest news on the vital sign monitoring front comes from Royal Philips, which recently published data on the effective monitoring of the absolute oxygen saturation of arterial blood.
Since its entry into life sciences in 2012, Alphabet has publicized several ambitious projects that experts are calling more "science fiction" than science--including the development of the "Tricorder," a diagnostic device straight out of Star Trek. But, despite the dubious achievability of its more futuristic efforts, the Silicon Valley giant's promise may lie in its more modest projects.
St. Jude Medical has been working for a couple of years to make the case for its tiny implantable heart failure monitor CardioMEMS--without much sales success thus far. But it gained a bit more fodder with the inclusion of the device to the European Society of Cardiology guidelines as a recommended tool to diagnose and treat acute and chronic heart failure.
In a big week for liquid biopsy, Guardant Health and Samsung Medical Center reported success from the first clinical trial using a blood test to match metastatic cancer patients to appropriate therapies.